AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s

TechNode

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

Accelerating Clinical Trial Recruitment with Artificial Intelligence and Natural Language Processing

Branded Content Archives · TechNode

Anthropic says its latest AI bot can beat Gemini and ChatGPT - The Verge

Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE (alpha-emitter) in Subjects With Somatostatin Receptor Positive NETs

Insilico Medicine achieves AI drug discovery breakthrough

A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE (alpha-emitter) in Subjects With Somatostatin Receptor Positive NETs

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes